Several years earlier, Theranos founder Elizabeth Holmes told Silicon Valley she would transform blood testing by using a single drop of blood to get fast, low-cost test results for everything from cholesterol to cancer. But earlier this year, the Securities and Exchange Commission called Theranos “an elaborate, years-long fraud” in which Holmes had persuaded investors to sink hundreds of millions of dollars into her company. Wall Street Journal investigative reporter John Carreyrou first broke that story and chronicles the collapse of Theranos in his new book, Bad Blood: Secrets and Lies in a Silicon Valley Startup.
John Carreyrou’s 'Bad Blood: Secrets and Lies in a Silicon Valley Startup'
Sponsored